ARROWHEAD PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 124M shares, a 16% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 124M +17.1M +16% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 124M +17.3M +16.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 108M +1.36M +1.28% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 107M +1.35M +1.28% Sep 30, 2023 10-Q 2024-08-08
Q2 2023 107M +1.31M +1.24% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 107M +1.17M +1.1% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 106M +1.34M +1.28% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 106M +1.63M +1.57% Sep 30, 2022 10-K 2023-11-29
Q2 2022 106M +1.59M +1.52% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 106M +1.68M +1.62% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 105M +1.6M +1.55% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 104M +1.95M +1.91% Sep 30, 2021 10-K 2022-11-28
Q2 2021 104M +1.96M +1.92% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 104M +2.27M +2.23% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 103M +2.08M +2.06% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 102M +6.87M +7.19% Sep 30, 2020 10-K 2021-11-22
Q2 2020 102M +7.04M +7.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 102M +7.08M +7.48% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 101M +8.52M +9.2% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 95.5M +7M +7.91% Sep 30, 2019 10-K 2020-11-23
Q2 2019 95.2M +7.35M +8.37% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 94.7M +7.1M +8.1% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 92.6M +17.7M +23.6% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 88.5M +13.7M +18.3% Sep 30, 2018 10-K 2019-11-25
Q2 2018 87.9M +13.1M +17.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 87.6M +12.8M +17.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 74.9M +505K +0.68% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 74.8M +5.04M +7.23% Sep 30, 2017 10-K 2018-12-11
Q2 2017 74.8M +14.3M +23.7% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 74.8M +14.8M +24.7% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 74.4M +14.8M +24.8% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 69.7M +10.2M +17.1% Sep 30, 2016 10-K 2017-12-12
Q2 2016 60.4M +931K +1.57% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 60M +525K +0.88% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 59.6M +4.91M +8.98% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 59.5M +4.89M +8.94% Sep 30, 2015 10-K 2016-12-14
Q2 2015 59.5M +6.59M +12.5% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 59.4M +7.57M +14.6% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 54.7M +15.7M +40.3% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 54.7M +22.2M +68.2% Sep 30, 2014 10-K 2015-12-14
Q2 2014 52.9M +21.6M +69% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 51.9M +34.8M +204% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 39M +23.4M +149% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 32.5M +18.9M +139% Sep 30, 2013 10-K 2014-11-25
Q2 2013 31.3M +20M +177% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 17M +6.24M +57.7% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 15.6M +5.11M +48.6% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 13.6M +4.94M +57.1% Sep 30, 2012 10-K 2013-12-18
Q2 2012 11.3M -60.5M -84.3% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 10.8M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 10.5M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 8.64M +1.47M +20.5% Sep 30, 2011 10-K 2012-12-28
Q2 2011 71.8M Jun 30, 2011 10-Q 2011-08-08
Q3 2010 7.17M Sep 30, 2010 10-K 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.